Merz Therapeutics

6 Decision Makers · 6 Verified Contacts

📍 Frankfurt, Hessen, GermanyFinance & Banking🗓 Est. 1908👥 501–1000 employees

About Merz Therapeutics

Merz Therapeutics is dedicated to improve the lives of patients in the field of neurotoxins.

Leadership & Decision Makers

Contact details of 6 Merz Therapeutics decision makers

Stefan Brinkmann

CEO

Stefan König

Chief Executive Officer

Philip Burchard

Chief Executive Officer

Sergey Golovko, CMA

Chief Financial Officer

augustin jerome

vice president Europe

Chad Duncan

Chief Financial Officer, North America

General Emails

General company emails, e.g. customer support lines

    info@merztherapeutics.com

    General Inquiries

Similar Companies like Merz Therapeutics

Blackstone Group

blackstone.com
Finance & Banking · New York, NY · Est. 1985 · 251–500 employees

HQ: New York, NY

Finance & Banking · Toronto, Ontario, Canada · Est. 1987 · 251–500 employees

HQ: Toronto, Ontario, Canada

BMO Capital Markets

capitalmarkets.bmo.com
Finance & Banking · Toronto, Ontario, Canada · Est. 1988 · 1001–5000 employees

HQ: Toronto, Ontario, Canada

Bain Capital

baincapital.com
Finance & Banking · Boston, MA · Est. 1984 · 1001–5000 employees · $500M–$1B

HQ: Boston, MA

Team8

team8.vc
Cybersecurity · Tel Aviv-yafo, Tel Aviv, Israel · Est. 2014 · 101–250 employees

HQ: Tel Aviv-yafo, Tel Aviv, Israel

Explore similar firms in the Finance & Banking sector

Company Info

Last updated: 28/07/2025

+49 (0)69 1503 0

Frankfurt, Hessen, Germany

Legal Name: Merz Therapeutics GmbH
Employees: 501-1000
Founded Date: 1908
Company Type: For Profit
Operating Status: Active
Phone Number: +49 (0)69 1503 0
Sub-Organization of: Merz Pharma
Last Investment Activity: May 15, 2024
Investments Activity: May 15, 2024 Apr 3, 2024 Apr 3, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.